Clinical Trial Update: A Clinical Trial to Study the Effects of Nanoparticle Based Paclitaxel Drug, Which Does Not Contain the Solvent Cremophor, in Advanced Breast Cancer [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update evaluating a cremophor-free, nanoparticle-based paclitaxel formulation for advanced breast cancer, sponsored by Fresenius Kabi Onc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Paclitaxel nanoparticle (cremophor-free) formulation (paclitaxel nanoparticle)

Snippet

Sponsor: Fresenius Kabi Oncology Ltd. | Conditions: Advanced Breast Cancer | Phase 1 | Status: UNKNOWN